CURATIVE BIOTECHNOLOGY

Curative Biotech is collaborating with the National Eye Institute (NEI), a part of the National Institutes of Health (NIH) under the terms of a Cooperative Research and Development Agreement (CRADA). Together we will be evaluating Curative's proprietary ocular metformin formulation in clinical studies for the treatment of intermediate and late-stage Age-Related Macular Degeneration (AMD) disease... Curative Biotech has established partnerships with several innovative organizations, including the National Institutes of Health, National Eye Institute, and Mid-Atlantic BioTherapeutics, Inc... At Curative Biotech, our unique business model coupled with our deep industry leadership experience enables us to build a pipeline of first in class drugs with accelerated development pathways to address the unmet medical needs of patients.

Also known as: Curative Biotech, Curative Biotechnology, Inc.